Subscriptions are live. Early access $24.99/mo, or start with 5 free premium days.
Plans & pricingDonateIndaptus Therapeutics, Inc. Common Stock
XNAS•Health Care•Pharmaceutical Preparations
Flagged at $3.29 at 10:11 AM on Sep 28, then ran to $3.83 +17% that session.
The high is the session peak after our first alert, not a realized trade. Not investment advice.
Why is INDP up today? It is at $3.18 (+6.35%), and our scanner flagged it 57 times on unusual volume this month. See the catalyst behind the move, real-time alerts the moment INDP spikes, and full due diligence on INDP — key stats, earnings, dilution and insider activity. Free.
Our scanner flagged $INDP 57 times in the last 30 days. Create a free account to track $INDP, build a watchlist, and get instant unusual-volume alerts, with a full day of premium now and 5 more when you verify your email, no card needed.
No card · 5 premium days · join 800+ traders
The top plays and unusual-volume catches our scanner flags, emailed to you. No account needed.
No spam. Unsubscribe anytime. Not investment advice.
Here is the latest on INDP from our scanner (live price and day move above). We have not detected an unusual-volume catalyst for INDP today, so it is trading in line with its recent range. The moment our scanner flags unusual activity, the reason will appear here.
Likely catalystOther Material Event, from an SEC filing. Read it →Latest filingSC 13D/AActivist 5%+ stake updatedOct 22, 2026 · yesterdayAcross every filing on file, supply equal to 196.9% of the tradeable float is in play - 196.9% more can still be issued.
Shelf sizes are dollars, so shares are estimated at today's price.
One filing exceeds the whole float, which usually means our share count is stale. Check the filing directly.
At-the-market (ATM) offering active — the company can keep selling new shares into the market over time (ongoing)
233,242,324 new shares · At-the-market (ATM) program — sells new shares into the market gradually over time · About $100.0M in size · Priced at $1.14/share
Sources: float & market cap via Polygon · short interest via FINRA · borrow & shortability via Alpaca · SSR from Reg SHO 201 · filings & dilution via SEC EDGAR · analysts via Nasdaq.
Auto-generated from public data for research and education. Not investment advice.
| Insider | Action | Shares | % of position | Owns after | Value | Date |
|---|---|---|---|---|---|---|
Ben-Tzvi Avraham Director | Acquired (grant/award) | +25K 0.02% of company | added 100% | 25K | n/a | Jan 20, 26 |
Newman Michael James Officer | Acquired (grant/award) | +52K 0.04% of company | added 100% | 101K | $106K at $2.03 | Dec 22, 25 |
Sassi Nir Officer | Acquired (grant/award) | +27K 0.02% of company | n/a | 27K | $54K at $2.03 | Dec 22, 25 |
Meckler Jeffrey A Officer | Acquired (grant/award) | +217K 0.2% of company | added 100% | 230K | $440K at $2.03 | Dec 22, 25 |
Linscott Walt Addison Officer | Acquired (grant/award) | +54K 0.04% of company | added 100% | 54K | $110K at $2.03 | Dec 22, 25 |
Meckler Jeffrey A Officer | Acquired (grant/award) | +6K | added 84% | 13K | $50K at $8.30 | Jul 27, 25 |
Recent Form-4 filings via Nasdaq. Open-market buys are the signal worth watching. Grants and automatic (10b5-1) sells are routine. “% of position” is the share of that insider’s own holding the trade moved. Not investment advice.
Blend of news sentiment, today’s move, and community votes. Not investment advice.
News, unusual-volume alerts, AI-trader trades and community chatter - the whole story, newest first.
The tickers our scanner is lighting up most over the last 48 hours.
Comparable names in pharmaceutical preparations, closest in size first.
Here is the latest on INDP from our scanner (live price and day move above). We have not detected an unusual-volume catalyst for INDP today, so it is trading in line with its recent range. The moment our scanner flags unusual activity, the reason will appear here.
INDP last traded at $3.18, up 6.35% on the day. The price and chart above update live during market hours (4 AM to 8 PM ET).
Indaptus Therapeutics, Inc. Common Stock (INDP) is next expected to report earnings on Wednesday, November 11, 2026, about 18 days away. Earnings reports often cause large overnight gaps, so many traders manage risk around the date. The date can shift until the company officially confirms it.
The INDP Live Alerts panel on this page streams real-time unusual volume (RVOL), momentum, halt and 200-EMA alerts from our scanner the moment they fire. Our scanner has flagged INDP 57 times in the last 30 days.
INDP (Indaptus Therapeutics, Inc. Common Stock) trades on XNAS, with a market cap of about $421M in the Pharmaceutical Preparations sector.
That depends on your strategy and risk. Day traders look for volume, volatility and a clear trend. Use the live chart, RVOL alerts and 200-EMA context on this page to judge INDP for yourself. This is not investment advice.
Live data from TheDesperateTrader scanner. Not investment advice.
$INDP discussion
Sign in to ask a question or join the discussion.